Literature DB >> 21959775

[Possible molecular mechanisms of spontaneous remission in sudden idiopathic hearing loss].

U-R Heinrich1, J Brieger, R H Stauber, W J Mann.   

Abstract

According to current knowledge, it must be assumed that temporary idiopathic hearing loss and its spontaneous remission are based on mechanical and/or pathological alterations in the inner ear. The causal mechanisms might be based on inter-individual variations. Induced by dose-dependent activators, temporary as well as permanent damage might occur. Sudden hearing loss may be initiated by an increase in the local nitric oxide (NO) concentration. Spontaneous remission, i.e. functional restoration, can be explained by a local decrease in the NO concentration. In this context, regulatory systems such as the gap-junction system, blood vessels or synapses might be affected. In addition, alterations in the hormone level of estrogen and mineralocorticoids, as well as cellular glutathione and vitamin levels, might lead to temporary alterations in the inner ear. Recent experimental findings indicate a role for the shuttle protein Survivin in the spontaneous remission of sudden hearing loss.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959775     DOI: 10.1007/s00106-011-2358-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  96 in total

Review 1.  Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes.

Authors:  James H Segars; Paul H Driggers
Journal:  Trends Endocrinol Metab       Date:  2002-10       Impact factor: 12.015

Review 2.  Idiopathic sudden hearing loss: contradictory clinical evidence, placebo effects and high spontaneous recovery rate--where do we stand in assessing treatment outcomes?

Authors:  Robert P Finger; Antoniu O Gostian
Journal:  Acta Otolaryngol       Date:  2006-12       Impact factor: 1.494

3.  Metabolic aspects of Meniere's disease.

Authors:  W H Powers
Journal:  Laryngoscope       Date:  1972-09       Impact factor: 3.325

Review 4.  Gap junction systems in the mammalian cochlea.

Authors:  T Kikuchi; R S Kimura; D L Paul; T Takasaka; J C Adams
Journal:  Brain Res Brain Res Rev       Date:  2000-04

5.  Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss.

Authors:  Gilda M Kalinec; Martin E Fernandez-Zapico; Raul Urrutia; Nora Esteban-Cruciani; Shanping Chen; Federico Kalinec
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-20       Impact factor: 11.205

6.  Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.

Authors:  Haralampos Gouveris; Oksana Selivanova; Wolf Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-04-29       Impact factor: 2.503

Review 7.  Survivin, cancer networks and pathway-directed drug discovery.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

8.  Aldosterone mediates an increase in [3H]ouabain binding at Na+, K(+)-ATPase sites in the mammalian inner ear.

Authors:  D Z Pitovski; M J Drescher; T P Kerr; D G Drescher
Journal:  Brain Res       Date:  1993-01-22       Impact factor: 3.252

9.  Bcl-2 gene therapy prevents aminoglycoside-induced degeneration of auditory and vestibular hair cells.

Authors:  Susanna C Pfannenstiel; Mark Praetorius; Peter K Plinkert; Douglas E Brough; Hinrich Staecker
Journal:  Audiol Neurootol       Date:  2009-01-19       Impact factor: 1.854

10.  Basal nitric oxide production contributes to membrane potential and vasotone regulation of guinea pig in vitro spiral modiolar artery.

Authors:  Zhi-Gen Jiang; Xiaorui Shi; Hui Zhao; Jun-Qiang Si; Alfred L Nuttall
Journal:  Hear Res       Date:  2004-03       Impact factor: 3.208

View more
  1 in total

1.  Vitamins A, C, and E and selenium in the treatment of idiopathic sudden sensorineural hearing loss.

Authors:  Hakan Kaya; Arzu Karaman Koç; İbrahim Sayın; Selçuk Güneş; Ahmet Altıntaş; Yakup Yeğin; Fatma Tülin Kayhan
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-12       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.